Stratos Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.11M Sell
70,550
-3,821
-5% -$366K 0.07% 292
2025
Q4
$7.14M Sell
74,371
-7,442
-9% -$723K 0.08% 250
2025
Q3
$7.79M Buy
81,813
+15,957
+24% +$1.47M 0.09% 226
2025
Q2
$5.74M Buy
65,856
+2,859
+5% +$242K 0.08% 259
2025
Q1
$5.66M Buy
62,997
+2,328
+4% +$208K 0.09% 235
2024
Q4
$4.85M Sell
60,669
-687
-1% -$59.5K 0.07% 281
2024
Q3
$5.52M Sell
61,356
-39
-0.1% -$3.28K 0.08% 249
2024
Q2
$4.83M Sell
61,395
-1,885
-3% -$155K 0.08% 252
2024
Q1
$5.51M Buy
63,280
+3,589
+6% +$306K 0.09% 230
2023
Q4
$4.92M Sell
59,691
-3,956
-6% -$302K 0.09% 228
2023
Q3
$4.99M Buy
63,647
+3,316
+5% +$278K 0.11% 200
2023
Q2
$5.32M Buy
60,331
+40,413
+203% +$3.48M 0.12% 185
2023
Q1
$1.61M Sell
19,918
-704
-3% -$57.4K 0.04% 369
2022
Q4
$1.6M Sell
20,622
-2,342
-10% -$190K 0.04% 392
2022
Q3
$1.85M Buy
22,964
+1,096
+5% +$98.5K 0.05% 330
2022
Q2
$1.96M Buy
21,868
+807
+4% +$81.8K 0.05% 324
2022
Q1
$2.34M Buy
21,061
+703
+3% +$74.3K 0.05% 325
2021
Q4
$2.11M Buy
20,358
+1,371
+7% +$159K 0.05% 341
2021
Q3
$2.38M Buy
18,987
+283
+2% +$36.6K 0.06% 285
2021
Q2
$2.32M Sell
18,704
-329
-2% -$41.3K 0.06% 295
2021
Q1
$2.25M Buy
19,033
+529
+3% +$62K 0.06% 271
2020
Q4
$2.17M Sell
18,504
-858
-4% -$94.5K 0.06% 261
2020
Q3
$2.01M Sell
19,362
-708
-4% -$71.1K 0.07% 261
2020
Q2
$1.84M Buy
20,070
+311
+2% +$29.8K 0.07% 266
2020
Q1
$1.78M Buy
19,759
+5,601
+40% +$596K 0.08% 230
2019
Q4
$1.61M Buy
14,158
+57
+0.4% +$6.25K 0.06% 284
2019
Q3
$1.53M Buy
14,101
+528
+4% +$55.1K 0.07% 275
2019
Q2
$1.32M Buy
13,573
+304
+2% +$27.8K 0.06% 293
2019
Q1
$1.21M Buy
13,269
+344
+3% +$30.8K 0.05% 317
2018
Q4
$1.18M Sell
12,925
-169
-1% -$15.8K 0.06% 300
2018
Q3
$1.29M Sell
13,094
-760
-5% -$70.3K 0.06% 286
2018
Q2
$1.19M Sell
13,854
-4,932
-26% -$412K 0.05% 324
2018
Q1
$1.51M Buy
18,786
+3,850
+26% +$318K 0.06% 280
2017
Q4
$1.21M Sell
14,936
-1,092
-7% -$87.5K 0.05% 309
2017
Q3
$1.25M Sell
16,028
-1,395
-8% -$116K 0.06% 295
2017
Q2
$1.55M Buy
17,423
+679
+4% +$57.3K 0.08% 233
2017
Q1
$1.35M Buy
16,744
+4,249
+34% +$332K 0.08% 231
2016
Q4
$890K Sell
12,495
-1,035
-8% -$81.3K 0.06% 282
2016
Q3
$1.17M Buy
+13,530
New +$1.18M 0.08% 219
2016
Q2
Sell
-11,238
Closed -$843K 654
2016
Q1
$843K Buy
11,238
+1,412
+14% +$106K 0.07% 210
2015
Q4
$756K Sell
9,826
-3,245
-25% -$244K 0.06% 219
2015
Q3
$875K Buy
13,071
+4,119
+46% +$303K 0.11% 164
2015
Q2
$663K Sell
8,952
-5,864
-40% -$448K 0.09% 209
2015
Q1
$1.15M Buy
14,816
+5,933
+67% +$450K 0.14% 151
2014
Q4
$641K Sell
8,883
-646
-7% -$44.9K 0.12% 182
2014
Q3
$590K Buy
9,529
+1,453
+18% +$92.4K 0.14% 147
2014
Q2
$513K Buy
+8,076
New +$491K 0.17% 151

Other funds holding MDT

Stratos Wealth Partners's MDT Position: Q1 2026 in Review

Stratos Wealth Partners reduced its Medtronic (MDT) stake by 5.1% in Q1 2026, selling an estimated $366K and leaving 70,550 shares worth $6.11M. The position accounts for 0.07% of the portfolio, ranked #292.

Stratos Wealth Partners first reported a position in MDT in Q2 2014 and has held it in 47 quarters since. The position peaked at $7.79M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Stratos Wealth Partners held 70,550 shares of Medtronic worth $6.11M as of Q1 2026.
  • Stratos Wealth Partners sold 3,821 Medtronic shares in Q1 2026, an estimated $366K.
  • Medtronic made up 0.07% of Stratos Wealth Partners's portfolio in Q1 2026, its #292 holding.
  • Stratos Wealth Partners first reported a position in Medtronic in Q2 2014 and has held it in 47 quarters since.
  • Stratos Wealth Partners's Medtronic position peaked at $7.79M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.